Cargando…
The need to move from 6-minute walk distance to outcome trials in pulmonary arterial hypertension
Assessment of change in exercise capacity using the 6-min walk distance (6MWD) test has been the primary end-point in the majority of pulmonary arterial hypertension (PAH) clinical trials. The 6MWD has some advantages as an end-point in such studies. It is simple and inexpensive to perform, reproduc...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Respiratory Society
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639189/ https://www.ncbi.nlm.nih.gov/pubmed/24293464 http://dx.doi.org/10.1183/09059180.00006213 |